Therapeutic Potential for Endothelin Receptor Antagonists in Cardiovascular Disorders

Author： Spieker L.E.   Noll G.   Lüscher T.F.  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.1, Iss.4, 2001-04, pp. : 293-303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mixed results with endothelin receptor antagonists in cardiovascular disorders

By  

Inpharma, Vol. 1, Iss. 1307, 2001-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

The therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular system

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1537-1552

Informa Healthcare

Access to resources Recommend Favorite

Development of endothelin receptor antagonists as potential therapeutic agents

By Ergul Adviye  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 1, 2003-01 ,pp. : 33-44

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of endothelin receptor antagonists in diabetes

By Chakrabarti S.   Cukiernik M.   Mukherjee S.   Chen S.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 12, 2000-12 ,pp. : 2873-2888

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of endothelin receptor antagonists and nitric oxide donors in pulmonary hypertension

By Tilton Ronald G   Brock Tommy A   Dixon Richard AF  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 7, 2001-07 ,pp. : 1291-1308

Informa Healthcare

Access to resources Recommend Favorite